GeneOne Life Science, Inc. (KRX:011000)
2,045.00
-15.00 (-0.73%)
Feb 21, 2025, 9:00 AM KST
GeneOne Life Science Revenue
GeneOne Life Science had revenue of 8.89B KRW in the quarter ending September 30, 2024, a decrease of -24.16%. This brings the company's revenue in the last twelve months to 37.97B, up 1.81% year-over-year. In the year 2023, GeneOne Life Science had annual revenue of 40.20B, down -17.48%.
Revenue (ttm)
37.97B
Revenue Growth
+1.81%
P/S Ratio
4.26
Revenue / Employee
825.42M
Employees
46
Market Cap
163.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
Dec 31, 2020 | 41.50B | 261.48M | 0.63% |
Dec 31, 2019 | 41.24B | 6.95B | 20.26% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Peptron | 2.41B |
Hanall Biopharma | 134.24B |